Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) O Chloromandelic Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106676140A reveals high-efficiency enzymatic synthesis. Offers supply chain stability and cost reduction for clopidogrel intermediates.
Novel chiral resolving agent enables high-purity (R)-o-chloromandelic acid production. Mature industrial route ensures supply chain stability and cost efficiency for pharmaceutical intermediates.
Novel nitrilase enables efficient production of chiral intermediates for clopidogrel with reduced environmental impact and scalable supply chain solutions.